Spironolactone further reduces urinary albumin excretion and plasma B-type natriuretic peptide levles in hypertensive type II diabetes treated with angiotensin-converting enzyme inhibitor

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 5-6, 2006, Pages 477-479

  Ogawa, Susumu ^a   Takeuchi, Kazuhisa ^a   Mori, Takefumi ^a   Nako, Kazuhiro ^a   Ito, Sadayoshi ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Albuminuria; Aldosterone escape; Angiotensin converting enzyme inhibitor; B type natriuretic peptide; Diabetic nephropathy; Furosemide; Hypertensive type II diabetes; Spironolactone

Indexed keywords

ALBUMIN; ALDOSTERONE; ALDOSTERONE ANTAGONIST; ANTIHYPERTENSIVE AGENT; BRAIN NATRIURETIC PEPTIDE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; IMIDAPRIL; SPIRONOLACTONE;

ABSENCE OF SIDE EFFECTS; ALBUMINURIA; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETIC HYPERTENSION; DIABETIC PATIENT; DISEASE SEVERITY; DRUG POTENTIATION; HEART FAILURE; HEART PROTECTION; HUMAN; HYPERKALEMIA; KIDNEY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; TREATMENT DURATION; URINARY EXCRETION;

ALBUMINURIA; ALDOSTERONE ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CREATININE; DIABETES MELLITUS, TYPE 2; DIURETICS; FUROSEMIDE; HUMANS; HYPERTENSION; IMIDAZOLIDINES; NATRIURETIC PEPTIDE, BRAIN; SPIRONOLACTONE; TREATMENT OUTCOME;

EID: 33745209933     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04390.x     Document Type: Article

References (4)

1. Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigations. N. Engl. J. Med. 1999 341 : 709 17.
2. Sato A, Hayashi K, Naruse M, Saruta T. Effectiveness of aldosterone blockade in patients with diabetic nephropathy. Hypertension 2003 41 : 64.
3. Schjoedt KJ, Andersen S, Rossing P, Tarnow L, Parving HH. Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate. Diabetologia 2004 47 : 1936 9.
4. Suzuki T, Yamaoki K, Nakajima O et al. Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels. Jpn Heart J. 2000 41 : 205 14.